TNDM - Tandem Diabetes Care, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.69
DETAILS
HIGH:
$55.00
LOW:
$21.00
MEDIAN:
$28.00
CONSENSUS:
$31.69
UPSIDE:
111.76%
AlphaVal
Deterministic, archetype-aware fair value
Distressed or Transitioning
75% confidence
Primary model: Current EPS × Depressed Multiple
Adjust Assumptions
7.5x
Key Value Driver
Whether the core business model is intact or structurally impaired
Implied Market Multiple
62.4x
Plain-Language Summary
Our base-case estimate uses Current EPS × Depressed Multiple. We then blend that result with the average analyst price target of $31.69 from 39 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $10.77 per share.
Warnings
Don't assume past cash flow levels will return — the company's troubles may have permanently reduced its ability to generate profits.
A stock can look cheap on paper and still lose half its value if the underlying business is permanently damaged.
The wide range between our best and worst cases is intentional — pretending to know a precise value for a troubled company would be misleading.
Wall Street's average price target is $31.69 (from 39 analysts). Our estimate is 94% below the consensus -- consider that gap carefully.
Key Risks
- Bullish DCF projections are fundamentally unknowable for distressed companies
- M&A speculation can floor the stock above intrinsic value temporarily
- Management credibility is a key input — new CEO expands the bull case